India vs Latvia: Number of isolates tested for ceftriaxone
India
8
in 2020
Latvia
7
in 2019
India rank
47th
Latvia rank
50th
Number of isolates tested for ceftriaxone over time
- India
- Latvia
How they compare
India currently reports 8 against 7 in Latvia, a difference of 1.
That makes India's figure about 1.1 times Latvia's.
Across all 9 years both countries report, India has been ahead every year.
India ranks 47th and Latvia ranks 50th of 52 countries.
India has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | India | Latvia | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 37 | 9 | 28 | India |
| 2010s | 63.5 | 18.88 | 44.62 | India |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher number of isolates tested for ceftriaxone, India or Latvia?
- India, at 8 against 7 in Latvia as of 2020.
- What is the difference in number of isolates tested for ceftriaxone between India and Latvia?
- 1, with India ahead.
- How many years of comparable data are there for India and Latvia?
- 9 years are reported by both, from 2009 to 2018.
- How do India and Latvia rank globally for number of isolates tested for ceftriaxone?
- India ranks 47th and Latvia ranks 50th of 52 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Number of isolates tested for ceftriaxone. Statizoid refreshes it automatically from the source and publishes the full history for both places.